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Large granular lymphocytes migrate in large numbers to
the pregnant uteri of a wide variety of mammalian species
(1). These cells, also known as granulated metrial gland
cells in rodents and endometrial granulocytes in primates,
will for the purposes of this review all be referred to as
uterine (u)NK cells. uNK cells are bone marrow–derived
leukocytes, but their immediate precursors may migrate
from the spleen. Cells expressing a similar panel of activa-
tion antigens are found in the spleens of pregnant but not
nonpregnant mice, and only splenocytes derived from
pregnant donors can populate the uteri of uNK-deficient
recipients during pregnancy (1, 2). The signals that regulate
migration of uNK to the uterus are not known. Homing
precedes implantation in rodents and primates, so it is un-
likely that the fetus plays a direct role. Circumstantial evi-
dence implicates ovarian steroids and uterine decidualiza-
tion, a metaplastic process that modifies the placental
implantation site during pregnancy (3). Mice lacking genes
for chemokines known to attract NK cells at other sites
show no defects in uNK localization (1). After migration,
uNK cells proliferate, differentiate, and accumulate in large
numbers in specific areas of the uterus between days 2.5
and 12 of murine pregnancy (implantation occurs on day 4
and delivery on day 19). After day 12, uNK cells undergo
extensive apoptosis (as defined by morphology and TdT
tailing) and are dramatically decreased in number and acti-
vation through the remainder of pregnancy (4–6). uNK
granules contain lytic molecules such as perforin and
granzymes A and B, matrix components including os-
teopontin, and vasoactive factors such as inducible nitric
oxide synthase (iNOS) and endothelial (e)NOS (6–8). Fac-
tors expressed in the uterus that are either bound by or oth-
erwise implicated in the regulation of uNK cells include
IL-15 (9), decidual prolactin-related peptide B (10), and
IFN-
 
g
 
. uNK cells can also be activated to secrete a variety
of cytokines including GM-CSF, CSF-1, leukemia inhibi-
tory factor, TGF-
 
b
 
1, TNF-
 
a
 
, and most importantly for the
purposes of this discussion, IFN-
 
g
 
 (8).
What is the justification for assigning uterine large gran-
ular lymphocytes to the NK lineage? Murine uNK cells ex-
press Thy 1.1, asialo-GM1, IL-15R
 
a
 
, and at least two
members of the CD94/NKG2 C-type lectin–like family of
class I MHC receptors, NKR-P1 (NK1.1) and Ly49G2
(LGL-1), and can lyse YAC-1 target cells (5, 6). Human
uNK cells express CD56 (polysialylated neural cell adhe-
sion molecule), members of the CD94/NKG2 and killer
inhibitory receptor (KIR)2D class I MHC receptor fami-
lies, and can lyse K562 target cells (11, 12). Despite having
these typical phenotypic and functional characteristics,
some doubt persists as to whether uNK cells truly belong to
the NK lineage. Part of the controversy is inherent to the
definition of NK cells. In the absence of any one lineage
specific marker, NK cells are essentially defined in negative
terms, i.e., cells of appropriate phenotype and function that
lack surface CD3/TCR molecules and show no molecular
evidence of Ig/TCR rearrangement (9). Lineage diagrams
depict an early separation of T lymphocytes and NK cells
before expression of the recombinase activating genes
RAG-1 and RAG-2. These definitions raise a more spe-
cific problem for uNK cells, the presence of an overlapping
population of uterine large granular lymphocytes that ex-
press 
 
g
 
/
 
d
 
 TCRs. A significant fraction of CD56
 
1
 
 human
uNK cells either express 
 
g
 
/
 
d
 
 TCRs or can acquire 
 
g
 
/
 
d
 
TCRs in culture (13). Based on these observations plus the
unusually high expression of RAG-1 and RAG-2 in
CD56
 
1
 
 human uNK cells (14), it has been suggested that
the human uterus could represent a site of extrathymic
maturation for 
 
g
 
/
 
d
 
 T cells analogous to cryptopatches in
the small intestine. A corresponding population of murine
 
g
 
/
 
d
 
 T cells has also been isolated, but their exact pheno-
type and localization within the pregnant uterus has not
been studied (15). Some evidence suggests that these cells
may regulate pregnancy viability in early gestation (day
5.5–8.5) and produce cytokines in response to trophoblast
antigens later in pregnancy (day 14–16) (16, 17). Whether
these cells are distinct from uNK cells is unknown. How-
 
ever, as virtually all uterine CD45
 
1
 
 leukocytes in the vi-
cinity of the placenta are by morphologic and immu-
nophenotypic criteria typical uNK cells, it is difficult to
accommodate a substantial independent population of 
 
g
 
/
 
d
 
T cells (6, 18). On balance, it seems reasonable at this point
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to assign uterine large granular lymphocytes to the NK lin-
eage, realizing that their taxonomy may change as further
data becomes available.
The recognition that uterine large granular lymphocytes
are probably NK cells coincided with the finding that inva-
sive trophoblasts in rodents and primates express class I
MHC molecules (11, 18). These observations both oc-
curred at a time of heightened interest in the mechanisms
by which a semiallogeneic fetus might survive in the histo-
incompatible mother. It had previously been thought that
trophoblasts lacked MHC expression, making them inef-
fective targets for a classical allogeneic response. The paired
observations that invasive trophoblasts express class I MHC
antigens and that uNK cells are prevalent in the pregnant
uterus led to the formulation of a hypothesis that has re-
mained pervasive in the field over the past decade: that tro-
phoblasts resist NK lysis by expressing class I MHC mole-
cules (later shown to the consequence of NK–class I
MHC-specific KIR) and that recognition of trophoblasts
by NK cells elicits the secretion of cytokines that both en-
hance placental growth and modulate local allogeneic re-
sponses (Th2 deviation). It is no exaggeration to state that
the number of reviews, editorials, conference reports, and
commentaries reiterating this hypothesis has far exceeded
the number of studies that have directly tested it. Unfortu-
nately, while heuristically satisfying, the uNK trophoblast
class I MHC hypothesis has not been particularly useful
thus far in explaining either normal placental development
or reproductive disorders such as abortion, growth retarda-
tion, preeclampsia, and fetal loss.
Careful morphologic assessment of normal and abnormal
pregnancies is a powerful tool to evaluate hypotheses re-
garding uNK function, and problems with the trophoblast
class I MHC hypothesis are readily apparent. Most of the
problems relate to the fact that for most of pregnancy, uNK
cells and trophoblasts are not in close temporal or anatomic
proximity to one another. Murine uNK cells accumulate
before implantation away from the implanting conceptus
and eventually concentrate in the metrial gland, a structure
located deep within the uterine musculature (19). The me-
trial gland is never infiltrated by trophoblasts but rather sur-
rounds large uterine arteries that supply the placenta (18).
Only late in pregnancy after extensive apoptosis and down-
regulation of both activation antigens and lytic activity do
uNK cells come in contact with trophoblasts in the decidua
basalis. Even at this stage, the majority of uNK cells are in
the metrial gland. Similarly, human uNK cells are primarily
clustered around endometrial glandular epithelium and
small arteries away from trophoblasts (20). The most in-
triguing observations relating to uNK function come from
rats and hamsters, rodent species that, unlike the mouse,
have deeply implanting placentas with uterine arteries that
are remodelled by invading trophoblastic cells (discussed
below). In these species, it has been shown that uNK cells
infiltrate the walls of uterine arteries before their invasion
by trophoblasts (21). Earlier in rat pregnancy, uNK cells
appear to have second distinct role: infiltration of endome-
trial epithelium surrounding the implantation cylinder im-
mediately before its incorporation into the endometrial
vasculature and long before contact with placental tropho-
blasts (22). The weight of the anatomic evidence does not
support a primary or direct role for uNK cells interacting
with trophoblasts but rather suggests a role for uNK in the
modification of uterine blood vessels and endometrial epi-
thelium away from the zones of trophoblast invasion and
placental morphogenesis.
Eschewing the trophoblast class I MHC hypothesis,
Croy et al. (1) have over the past 10 years pursued an alter-
native genetic approach supplemented by careful morpho-
logic analysis. This group has focused on two questions:
What defects would be seen in pregnancies derived from
mothers without uNK cells, and What manipulations
would be required overcome uNK deficiency and restore
normal morphology? Answering these questions was ini-
tially hampered by the lack of an appropriate model of
uNK deficiency. Studies with SCID mice argued against a
substantial role for adaptive immunity in placental mor-
phology and pregnancy outcome. 
 
beige/beige
 
 mice with de-
fective NK lytic activity also had essentially normal preg-
nancies, as did doubly mutant SCID/
 
beige
 
 mice (8).
Subsequent analysis of many immunodeficient mouse
strains revealed two with absent uNK cells, tg
 
e
 
26 females
having an insertional mutation involving multiple copies of
the human CD3E gene and mice doubly mutant for p56
lck and IL-2R
 
b
 
. Six well defined pregnancy abnormalities
were described in these animals: absence of uNK cells, no
metrial gland, decreased placental size, increased fetal loss,
decidual edema, and most importantly an arteriopathy in-
volving the large maternal arteries supplying the placenta.
This arteriopathy was characterized by hypertrophy of the
muscular media and narrowing of the vascular lumen (de-
fective vascular remodeling). All six defects were corrected
by transplantation of normal bone marrow just before preg-
nancy. The results of the study by Ashkar et al. in this issue
provide further insights into the etiology and mechanisms
of uNK deficiency arteriopathy (23). For this study, a third
uNK-deficient mouse, doubly mutant for RAG-2 and the
common cytokine 
 
g
 
 receptor subunit, was used. These
mice received either bone marrow transplants from donors
lacking key uNK-regulatory molecules or daily cytokine
infusions to define the minimum requirements for restora-
tion of normal morphology. Three conclusions emerged.
First, low levels of endogenous (non–uNK-derived) IFN-
 
g
 
are required to maintain decidual integrity at day 12–14 of
pregnancy. Second, higher levels of IFN-
 
g
 
, normally de-
rived from uNK but substituted for by daily infusions of
IFN-
 
g
 
, are needed for vascular remodelling (day 10–12).
Third, an intact IFN-
 
g
 
 signal transduction pathway is re-
quired in donor cells for normal uNK (and metrial gland)
development. However, donors lacking IFN-
 
g
 
 signal
transduction function were still able to appropriately re-
model uterine arteries, suggesting that the uNK abnormali-
ties observed in these mice did not interfere with the avail-
ability of IFN-
 
g
 
.
Vascular remodelling is a relatively recent concept now
believed to occur in a variety of situations characterized by 
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inadequate perfusion or increased vascular demand (24).
Mediated by changes in local cytokines, growth factors, va-
soregulatory substances, matrix components, and matrix
proteases, this process culminates in permanent structural
alterations, including thinning of the vascular muscle wall
and with luminal dilatation, which increase local perfusion.
Although unfamiliar to many immunologists, vascular re-
modelling has been of considerable recent interest in repro-
ductive biology. It has long been known that maternal ar-
teries supplying the human placenta are invaded by fetal
trophoblasts, which replace the muscular media with a fi-
brinoid matrix, leading to increased blood flow (21). Re-
cent data have shown that this trophoblast-dependent pro-
cess is preceded by a trophoblast-independent phase of
vascular remodelling (25). As shown most convincingly by
Ashkar et al. (23), trophoblast-independent remodelling of
uterine arteries in rodents appears to be uNK dependent.
Although human uNK cells have not yet been implicated
in vascular remodelling, it is notable that 
 
z
 
10% of human
uNK cells cluster around uterine arteries undergoing vascu-
lar remodelling (20). Recent data has shown that decreased
oxygen tension leads to impaired trophoblast differentiation
and trophoblast-dependent arterial remodelling, both of
which are characteristic of the human pregnancy disorder
preeclampsia (26). In light of these recent data, the follow-
ing hypothesis is suggested. Defects in early vascular re-
modelling related to uNK dysfunction lead to local hy-
poxia, which retards trophoblast differentiation and inhibits
trophoblast-dependent vascular remodelling. The resulting
reduction in uteroplacental perfusion would then increase
the risk of preeclampsia and related pregnancy disorders
such as growth retardation and unexplained fetal loss. The
uNK-deficient murine model, although lacking the tro-
phoblast-dependent vascular remodelling component, sup-
ports such a model and implicates uNK-derived IFN-
 
g 
 
as a
possible mediator.
With regard to future investigation, three obvious ques-
tions stand out: the relationship of murine uNK to 
 
g
 
/
 
d
 
 T
cells throughout gestation and their relative functionality,
the downstream pathways mediating murine IFN-
 
g
 
–depen-
dent vascular remodelling, and the relationship of human
uNK cells to abnormal vascular remodelling in preeclamp-
sia and related disorders.
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